Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole for Prevention of Aspirin-Induced Gastroduodenal Injury
NCT00220857Phase 4Completed
- Sponsor
- Temple University
- Start
- Sep 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Rabeprazole with Placebo (2 arms). Primary endpoint: Gastric mucosal abnormalities (Lanza score, hemorrhages, erosions) at Day 4. Started Sep 2005; status: completed.
02
Drugs
rabeprazole
Beyond the preview
Go deeper on NCT00220857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220857.